Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Status:
Completed

Trial end date:
2019-06-27

Target enrollment:

Participant gender:

Randomized, double-blind, placebo-controlled investigating the efficacy of tradipitant in the treatment of motion sickness.

Phase 2

Vanda Pharmaceuticals